| |
| |
|
| Insider
Information: |
Greer R Scott |
| Relationship: |
Director |
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
745,685 |
|
|
Indirect Shares
|
29,703 |
|
|
| Direct
Value |
$905,758 |
|
|
|
Indirect Value
|
$236,139 |
|
|
| Total
Shares |
775,388 |
|
|
| Total
Value |
$1,141,897 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CV Therapeutics Inc |
CVTX |
Director |
2003-12-12 |
18,000 |
2003-12-12 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2022-09-16 |
303,574 |
|
0 |
Premium* |
|
|
Microbot Medical Inc |
MBOT |
Director |
2016-01-01 |
290,183 |
|
0 |
Premium* |
|
|
Auspex Pharmaceuticals, Inc. |
ASPX |
Director |
2015-05-05 |
0 |
|
0 |
Premium* |
|
|
Sientra, Inc. |
SIEN |
Director |
2018-06-05 |
58,773 |
|
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
44,380 |
|
0 |
Premium* |
|
|
Inogen Inc |
INGN |
Director |
2021-05-10 |
30,775 |
2021-05-10 |
29,703 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
303,574 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-11-09 |
4 |
OE |
$12.80 |
$160,000 |
D/D |
12,500 |
293,374 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
146,342 |
290,183 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
280,874 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-08-31 |
4 |
OE |
$12.70 |
$571,500 |
D/D |
45,000 |
270,674 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-01-05 |
4 |
OE |
$13.80 |
$552,000 |
D/D |
40,000 |
225,674 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2011-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
210,000 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2010-06-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-07-09 |
4 |
OE |
$9.24 |
$369,600 |
D/D |
40,000 |
191,583 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,100 |
185,674 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-07-09 |
4 |
AS |
$25.00 |
$375,225 |
D/D |
(15,009) |
176,574 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-04-06 |
4 |
OE |
$14.26 |
$427,800 |
D/D |
30,000 |
160,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
151,583 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-03-08 |
4 |
OE |
$5.14 |
$51,400 |
D/D |
10,000 |
145,083 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
58,253 |
143,841 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-04 |
4 |
OE |
$5.14 |
$51,400 |
D/D |
10,000 |
140,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-06-06 |
4 |
OE |
$5.14 |
$44,204 |
D/D |
8,600 |
138,933 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,750 |
135,083 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-06-04 |
4 |
OE |
$5.14 |
$7,196 |
D/D |
1,400 |
131,733 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-04-06 |
4 |
AS |
$92.22 |
$2,766,600 |
D/D |
(30,000) |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-06-04 |
4 |
AS |
$61.99 |
$86,786 |
D/D |
(1,400) |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-06-06 |
4 |
AS |
$60.00 |
$516,000 |
D/D |
(8,600) |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-04 |
4 |
AS |
$67.39 |
$673,900 |
D/D |
(10,000) |
130,333 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2016-10-24 |
4 |
B |
$13.50 |
$202,500 |
D/D |
15,000 |
121,333 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
